Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne B Hendrix

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Alzheimer'S Research & Therapy|April 5, 2011
Requiring an amyloid-β1-42 biomarker may improve the efficiency of a study, and simulations may help in planning studiesSuzanne B Hendrix
Alzheimer'S Research & Therapy|July 19, 2012
Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over timeSuzanne B Hendrix
Alzheimer'S Research & Therapy|May 18, 2013
Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's diseaseSuzanne B Hendrix, Kathleen A Welsh-Bohmer
The American Journal of Orthopsychiatry|May 29, 2003
Gender, types of conflict, and individual differences in the use of violent and peaceful strategies among children who have and have not witnessed interparental violenceBonnie Ballif-Spanvill, Claudia J Clayton, Suzanne B Hendrix
The American Journal of Orthopsychiatry|May 31, 2007
Witness and nonwitness children's violent and peaceful behavior in different types of simulated conflict with peersBonnie Ballif-Spanvill, Claudia J Clayton, Suzanne B Hendrix
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentKent Hendrix, Craig Mallinckrodt, Suzanne B Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentCraig Mallinckrodt, Suzanne B Hendrix, Kent Hendrix, et al.
Alzheimer'S Research & Therapy|May 24, 2023
Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA reviewSamuel P Dickson, Sean Hennessey, Jessie Nicodemus Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCaleb W Dayley, Samuel P Dickson, Kent Hendrix, et al.
Statistics in Medicine|May 18, 2026
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive DiseasesFlorian Stijven, Craig Mallinckrodt, Geert Molenberghs, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Alzheimer'S Research & Therapy|April 5, 2011
Requiring an amyloid-β1-42 biomarker may improve the efficiency of a study, and simulations may help in planning studiesSuzanne B Hendrix
Alzheimer'S Research & Therapy|July 19, 2012
Measuring clinical progression in MCI and pre-MCI populations: enrichment and optimizing clinical outcomes over timeSuzanne B Hendrix
Alzheimer'S Research & Therapy|May 18, 2013
Separation of cognitive domains to improve prediction of progression from mild cognitive impairment to Alzheimer's diseaseSuzanne B Hendrix, Kathleen A Welsh-Bohmer
The American Journal of Orthopsychiatry|May 29, 2003
Gender, types of conflict, and individual differences in the use of violent and peaceful strategies among children who have and have not witnessed interparental violenceBonnie Ballif-Spanvill, Claudia J Clayton, Suzanne B Hendrix
The American Journal of Orthopsychiatry|May 31, 2007
Witness and nonwitness children's violent and peaceful behavior in different types of simulated conflict with peersBonnie Ballif-Spanvill, Claudia J Clayton, Suzanne B Hendrix
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentKent Hendrix, Craig Mallinckrodt, Suzanne B Hendrix, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentCraig Mallinckrodt, Suzanne B Hendrix, Kent Hendrix, et al.
Alzheimer'S Research & Therapy|May 24, 2023
Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA reviewSamuel P Dickson, Sean Hennessey, Jessie Nicodemus Johnson, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentCaleb W Dayley, Samuel P Dickson, Kent Hendrix, et al.
Statistics in Medicine|May 18, 2026
Time-Scale Target Parameters and Two-Step Estimation in Longitudinal Trials for Progressive DiseasesFlorian Stijven, Craig Mallinckrodt, Geert Molenberghs, et al.
Pageof 4